Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunoneutralization of chemokines for the prevention and treatment of central nervous system autoimmune disease.

Methods (San Diego, Calif.) - 1 Apr 2003

Karpus William J, Fife Brian T, Kennedy Kevin J

Abstract excerpt

Chemokine-induced lymphocyte migration has long been hypothesized to regulate the appearance and continued presence of lymphocytes and monocytes in tissue-specific autoimmune diseases, including central nervous system autoimmune diseases such as multiple sclerosis. For instance, a large body of evidence points to the temporal association of chemokine expression with the appearance of T lymphocytes and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmune Diseases
Share to Central Nervous System Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemokines

Share to Encephalomyelitis, Autoimmune, Experimental

Share to Lymphocytes

Share to Mice, Inbred C57BL

Share to Time Factors

Source

Identifiers

PMID: 12725803
DOI: 10.1016/s1046-2023(02)00360-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunoneutralization of chemokines for the prevention and treatment of central nervous system autoimmune disease.PMID 12725803Read ↗

The use of chemokine antagonists in EAE models.Semantic proximity Read ↗

Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.Semantic proximity Read ↗

Targeting CXCL13 During NeuroinflammationSemantic proximity Read ↗

Genetic deletion of Autotaxin from CD11b <sup>+</sup> cells decreases the severity of experimental autoimmune encephalomyelitisSemantic proximity Read ↗

Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system.Semantic proximity Read ↗

IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.Semantic proximity Read ↗

Efficient T-cell surveillance of the CNS requires expression of the CXC chemokine receptor 3.Semantic proximity Read ↗

Treatment of Experimental Autoimmune Encephalomyelitis with Genetically Modified Memory T CellsSemantic proximity Read ↗

Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse.Semantic proximity Read ↗

Aberrant T cell migration toward RANTES and MIP-1alpha in patients with multiple sclerosis: Overexpression of chemokine receptor CCR5Semantic proximity Read ↗

T-cell properties determine disease site, clinical presentation, and cellular pathology of experimental autoimmune encephalomyelitis.Semantic proximity Read ↗

Role of CD8 <sup>+</sup> T Cells in Murine Experimental Allergic EncephalomyelitisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.